WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996004257) CRYSTALLINE FORM OF AN ANTIFUNGAL AZOLE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/004257    International Application No.:    PCT/GB1995/001816
Publication Date: 15.02.1996 International Filing Date: 01.08.1995
Chapter 2 Demand Filed:    19.02.1996    
IPC:
C07D 521/00 (2006.01)
Applicants: ZENECA LIMITED [GB/GB]; 15 Stanhope Gate, London W1Y 6LN (GB) (For All Designated States Except US).
MOCHIDA PHARMACEUTICAL CO. LTD. [JP/JP]; 7, Yotsuya 1-chome, Shinjuku-ku, Tokyo 160 (JP) (KR, SG only).
LADD, Richard, Maurice [GB/GB]; (GB) (For US Only).
CHEETHAM, Francis, David [GB/GB]; (GB) (For US Only).
MOBBS, Bryan, Edward [GB/GB]; (GB) (For US Only)
Inventors: LADD, Richard, Maurice; (GB).
CHEETHAM, Francis, David; (GB).
MOBBS, Bryan, Edward; (GB)
Agent: DENERLEY, Paul, Millington; Intellectual Property Group, Intellectual Property Dept., ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG (GB)
Priority Data:
9415617.1 02.08.1994 GB
Title (EN) CRYSTALLINE FORM OF AN ANTIFUNGAL AZOLE
(FR) FORME CRISTALLINE D'UN AZOLE ANTIFONGIQUE
Abstract: front page image
(EN)A crystalline form of the antifungal agent (+)-2-(2,4-difluorophenyl)-1-[3-[(E)-4-(2,2,3,3-tetrafluoropropoxy)-styryl]-1H-1,2,4-triazol-1-yl]-3- (1H-1,2,4-triazol-1-yl)propan-2-ol (code D0870) is described. Furthermore processes for the preparation thereof, to pharmaceutical compositions comprising said crystalline form and to the use thereof in therapy are described.
(FR)L'invention concerne une forme cristalline de l'agent antifongique (+)-2-(2,4-difluorophényle)-1-(3-((E)-4-(2,2,3,3-tétrafluoropropoxy)-styryle)-1H-1,2,4-triazole-1-yle)-3-(1H-1,2,4-triazole-1-yle)propane-2-ol (code D0870). Elle concerne également des procédés servant à la préparer, des compositions pharmaceutiques comprenant ladite forme cristalline, ainsi que son utilisation thérapeutique.
Designated States: AM, AT, AU, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, ES, FI, GB, GE, HU, JP, KE, KG, KP, KR, KZ, LK, LT, LU, LV, MD, MG, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, MW, SD, SZ, UG)
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)